Contact Paul Mraz
Title CEO


The unique ApiFix approach provides a viable alternative to bracing and spinal fusion for many patients as the least invasive spine deformity correction option. The MID-C system acts as an “internal brace” and incorporates a patented unidirectional and self-adjusting rod mechanism with motion-preserving polyaxial joints that allows for additional post-operative correction over time and is removable. The ApiFix device is implanted in a unilateral posterior procedure where patient recovery is relatively pain-free and is measured in days, not months.

Company News

OrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. with FDA-Approved Non-Fusion Scoliosis Technology

DateApr 1, 2020
Mark Throdahl, President and Chief Executive Officer of OrthoPediatrics, commented, “We believe that ApiFix fills a major treatment gap that could potentially allow patients to avoid fusion surgery. We estimate that non-fusion procedures will grow significantly as patients, their families, and surgeons recognize non-fusion’s benefits."
Read More →